Cargando…

Safety and efficacy of travoprost solution for the treatment of elevated intraocular pressure

Travoprost is a prostaglandin analogue widely used for reducing intraocular pressure (IOP) in patients affected with glaucoma and ocular hypertension. It exerts its ocular hypotensive effect through the prostaglandin FP receptors, located in the ciliary muscle and the trabecular meshwork. Several st...

Descripción completa

Detalles Bibliográficos
Autores principales:	Quaranta, Luciano, Riva, Ivano, Katsanos, Andreas, Floriani, Irene, Centofanti, Marco, Konstas, Anastasios G P
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2015
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4401333/ https://www.ncbi.nlm.nih.gov/pubmed/25914522 http://dx.doi.org/10.2147/OPTH.S61444

Ejemplares similares

Erratum to: Quality of Life in Glaucoma: A Review of the Literature
por: Quaranta, Luciano, et al.
Publicado: (2016)

Latanoprost ophthalmic solution in the treatment of open angle glaucoma or raised intraocular pressure: a review
por: Russo, Andrea, et al.
Publicado: (2008)

Sustained intraocular pressure reduction throughout the day with travoprost ophthalmic solution 0.004%
por: Dubiner, Harvey B, et al.
Publicado: (2012)

Sustainability of Intraocular Pressure Reduction of Travoprost Ophthalmic Solution in Subjects with Normal Tension Glaucoma
por: Naito, Tomoko, et al.
Publicado: (2016)

Vision-related quality of life and symptom perception change over time in newly-diagnosed primary open angle glaucoma patients
por: Riva, Ivano, et al.
Publicado: (2019)

Author Correction: Vision-related quality of life and symptom perception change over time in newly-diagnosed primary open angle glaucoma patients
por: Riva, Ivano, et al.
Publicado: (2020)

Diurnal and 24-h Intraocular Pressures in Glaucoma: Monitoring Strategies and Impact on Prognosis and Treatment
por: Konstas, Anastasios G., et al.
Publicado: (2018)

Ahmed glaucoma valve implant: surgical technique and complications
por: Riva, Ivano, et al.
Publicado: (2017)

Effect of travoprost on 24-hour intraocular pressure in normal tension glaucoma
por: Nomura, Yuya, et al.
Publicado: (2010)

Quality of Life in Glaucoma: A Review of the Literature
por: Quaranta, Luciano, et al.
Publicado: (2016)

Management of exfoliative glaucoma: challenges and solutions
por: Holló, Gábor, et al.
Publicado: (2015)

Efficacy and Safety of PreserFlo(®) MicroShunt After a Failed Trabeculectomy in Eyes with Primary Open-Angle Glaucoma: A Retrospective Study
por: Quaranta, Luciano, et al.
Publicado: (2021)

Feasibility study of sustained-release travoprost punctum plug for intraocular pressure reduction in an Asian population
por: Perera, Shamira A, et al.
Publicado: (2016)

24-h Efficacy of Glaucoma Treatment Options
por: Konstas, Anastasios G. P., et al.
Publicado: (2016)

The effects of selective laser trabeculoplasty and travoprost on circadian intraocular pressure fluctuations: A randomized clinical trial
por: Kiddee, Weerawat, et al.
Publicado: (2017)

Efficacy, safety, and improved tolerability of travoprost BAK-free ophthalmic solution compared with prior prostaglandin therapy
por: Henry, J Charles, et al.
Publicado: (2008)

Erratum to: 24-h Efficacy of Glaucoma Treatment Options
por: Konstas, Anastasios G. P., et al.
Publicado: (2016)

Efficacy of travoprost for the treatment of patients with glaucoma
por: Zhang, Xiu-Li, et al.
Publicado: (2019)

The Mont Blanc Study: The effect of altitude on intra ocular pressure and central corneal thickness
por: Bruttini, Carlo, et al.
Publicado: (2020)

Combined Pupilloplasty and Retropupillary Iris-Claw Intraocular Lens Implantation with DSAEK in a Patient with Traumatic Iridoplegia, Aphakia and Corneal Decompensation
por: Mikropoulos, Dimitrios G., et al.
Publicado: (2019)

Travoprost with sofZia® preservative system lowered intraocular pressure of Japanese normal tension glaucoma with minimal side effects
por: Mizoue, Shiro, et al.
Publicado: (2014)

Effect on Intraocular Pressure of Switching from Latanoprost and Travoprost Monotherapy to Timolol Fixed Combinations in Patients with Normal-Tension Glaucoma
por: Igarashi, Ryoko, et al.
Publicado: (2014)

Physiology-Enhanced Data Analytics to Evaluate the Effect of Altitude on Intraocular Pressure and Ocular Hemodynamics
por: Vercellin, Alice Verticchio, et al.
Publicado: (2022)

Differential Protein Expression Profiles in Glaucomatous Trabecular Meshwork: An Evaluation Study on a Small Primary Open Angle Glaucoma Population
por: Micera, Alessandra, et al.
Publicado: (2016)

Efficacy of the travoprost/timolol fixed combination versus the concomitant use of travoprost 0.004% and timolol 0.1% gel formulation
por: Kozobolis, Vassilios, et al.
Publicado: (2018)

Ocular Surface Disease with BAK preserved Travoprost and Polyquaternium 1(Polyquad) preserved Travoprost
por: Kumar, Suresh, et al.
Publicado: (2019)

Effect of benzalkonium chloride–free travoprost on intraocular pressure and ocular surface symptoms in patients with glaucoma previously on latanoprost: an open-label study
por: Lopes, Joao F., et al.
Publicado: (2015)

Efficacy and patient tolerability of travoprost BAK-free solution in patients with open-angle glaucoma and ocular hypertension
por: Mirza, Sophia K, et al.
Publicado: (2010)

A case report of pediatric neurotrophic keratopathy in pontine tegmental cap dysplasia treated with cenegermin eye drops
por: Fausto, Riccardo, et al.
Publicado: (2020)

Efficacy and safety of travoprost alone or in combination with other agents for glaucoma and ocular hypertension: patient considerations
por: Suzuki, Emilio Rintaro, et al.
Publicado: (2010)

A Review of the Clinical Usefulness of Selective Laser Trabeculoplasty in Exfoliative Glaucoma
por: Katsanos, Andreas, et al.
Publicado: (2018)

24-Hour Efficacy and Ocular Surface Health with Preservative-Free Tafluprost Alone and in Conjunction with Preservative-Free Dorzolamide/Timolol Fixed Combination in Open-Angle Glaucoma Patients Insufficiently Controlled with Preserved Latanoprost Monotherapy
por: Konstas, Anastasios-Georgios, et al.
Publicado: (2016)

Efficacy and safety of travoprost/timolol vs dorzolamide/timolol in patients with open-angle glaucoma or ocular hypertension
por: Teus, Miguel A, et al.
Publicado: (2009)

Correction to: 24-Hour Efficacy and Ocular Surface Health with Preservative-Free Tafluprost Alone and in Conjunction with Preservative-Free Dorzolamide/Timolol Fixed Combination in Open-Angle Glaucoma Patients Insufficiently Controlled with Preserved Latanoprost Monotherapy
por: Konstas, Anastasios-Georgios, et al.
Publicado: (2020)

Fixed combination of travoprost and timolol maleate reduces intraocular pressure in Japanese patients with primary open-angle glaucoma or ocular hypertension: analysis by prostaglandin analogue
por: Nakano, Tadashi, et al.
Publicado: (2016)

Late-day intraocular pressure–lowering efficacy and tolerability of travoprost 0.004% versus bimatoprost 0.01% in patients with open-angle glaucoma or ocular hypertension: a randomized trial
por: DuBiner, Harvey B, et al.
Publicado: (2014)

Travoprost Induced Granulomatous Anterior Uveitis
por: Chiam, Patrick
Publicado: (2011)

Pooled results of two randomized clinical trials comparing the efficacy and safety of travoprost 0.004%/timolol 0.5% in fixed combination versus concomitant travoprost 0.004% and timolol 0.5%
por: Gross, Ronald L, et al.
Publicado: (2007)

A Comparison of Hyper-Reflective Retinal Spot Counts in Optical Coherence Tomography Images from Glaucomatous and Healthy Eyes
por: Quaranta, Luciano, et al.
Publicado: (2021)

Dorzolamide/Timolol Fixed Combination: Learning from the Past and Looking Toward the Future
por: Konstas, Anastasios G., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_6l2mb2ogi09ko12l7ue4gnuui6